BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Burki TK. Fruquintinib for previously treated metastatic colorectal cancer. Lancet Oncol 2018;19:e388. [PMID: 29983343 DOI: 10.1016/S1470-2045(18)30503-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Zou JY, Wang Z, Wang Y. Fruquintinib: a novel antivascular endothelial growth factor receptor tyrosine kinase inhibitor for the treatment of metastatic colorectal cancer. Cancer Manag Res. 2019;11:7787-7803. [PMID: 31496821 DOI: 10.2147/cmar.s215533] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
2 Zhao L, Yu Q, Gao C, Xiang J, Zheng B, Feng Y, Li R, Zhang W, Hong X, Zhan Y, Xiao L, Hu T. Studies of the Efficacy of Low-Dose Apatinib Monotherapy as Third-Line Treatment in Patients with Metastatic Colorectal Cancer and Apatinib’s Novel Anticancer Effect by Inhibiting Tumor-Derived Exosome Secretion. Cancers 2022;14:2492. [DOI: 10.3390/cancers14102492] [Reference Citation Analysis]
3 Zhang Y, Zou JY, Xu YY, He JN. Fruquintinib beneficial in elderly patient with neoplastic pericardial effusion from rectal cancer: A case report. World J Clin Cases 2021; 9(21): 6170-6177 [PMID: 34368339 DOI: 10.12998/wjcc.v9.i21.6170] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Liu X, Guo A, Tu Y, Li W, Li L, Liu W, Ju Y, Zhou Y, Sang A, Zhu M. Fruquintinib inhibits VEGF/VEGFR2 axis of choroidal endothelial cells and M1-type macrophages to protect against mouse laser-induced choroidal neovascularization. Cell Death Dis 2020;11:1016. [PMID: 33247124 DOI: 10.1038/s41419-020-03222-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Nalli M, Puxeddu M, La Regina G, Gianni S, Silvestri R. Emerging Therapeutic Agents for Colorectal Cancer. Molecules 2021;26:7463. [DOI: 10.3390/molecules26247463] [Reference Citation Analysis]
6 Mei YB, Luo SB, Ye LY, Zhang Q, Guo J, Qiu XJ, Xie SL. Validated UPLC-MS/MS method for quantification of fruquintinib in rat plasma and its application to pharmacokinetic study. Drug Des Devel Ther 2019;13:2865-71. [PMID: 31616134 DOI: 10.2147/DDDT.S199362] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]